Dipanshu Sur and Ratnabali Chakravorty
By reviewing of previous studies, concentrating on recent systematic reviews and large prospective studies tries to give a clear picture with epidemiological evidence about the present scenario of cervical cancer control and HPV (Human Papilloma Virus) in India. Cervical cancer is the second most common cancer among women worldwide and most common malignancy in developing countries, particularly in India. It is unique among cancers in that it can largely be prevented through screening and removal of pre-cursor lesions. Nowadays, cervical screening for women is necessary because there are no signs and symptoms of cervical pre-cancers. The establishment of a prevention program is urgently required considering both screening and vaccination. But most women in India do not have access to effective screening programmes. It has been estimated that in India, even with a major effort to expand cytology services, it will not be possible to screen most of the population once in a lifetime in the near future. New HPV vaccines will also help prevent HPV infection and the pre-cancerous changes that lead to cervical cancer. The focus on identification and prevention of cervical cancer must be emphasized in a highly populated country like India to prevent its extensive blowout.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 